Thiogenesis Therapeutics Market Cap

Thiogenesis Therapeutics has a market cap or net worth of CAD 32.66 million as of December 5, 2025. Its market cap has increased by 5.56% in one year.

Market Cap

32.66M

Enterprise Value

29.15M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.62

Market Cap Chart

Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 32.66M, an increase of 134.01%. That is a compound annual growth rate of 26.24%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	33.18M	20.15%
Dec 31, 2024	27.61M	-17.40%
Dec 29, 2023	33.43M	48.30%
Dec 30, 2022	22.54M	61.52%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Curaleaf Holdings	2.50B
dentalcorp Holdings	2.18B
Green Thumb Industries	2.06B
Sienna Senior Living	1.92B
Extendicare	1.71B
Trulieve Cannabis	1.43B
Cronos Group	1.31B
WELL Health Technologies	931.75M

Market Cap Rankings